HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,370
-220 (-1.41%)
Oct 31, 2025, 3:30 PM KST

HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 215.83 billion as of October 31, 2025. Its market cap has decreased by -41.11% in one year.

Market Cap
215.83B
Enterprise Value
203.48B
Revenue
36.10B
Ranking
n/a
PE Ratio
456.63
Stock Price
15,370.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 215.83B, an increase of 156.09%. That is a compound annual growth rate of 10.00%.

History

DateMarket Cap% Change
Oct 30, 2025218.92B-35.31%
Dec 30, 2024338.42B58.45%
Dec 28, 2023213.58B43.49%
Dec 29, 2022148.85B-21.48%
Dec 30, 2021189.57B-21.05%
Dec 30, 2020240.12B219.34%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 21, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Samsung Biologics87.69T
Celltrion39.50T
ALTEOGEN25.46T
SK Biopharmaceuticals9.08T
Yuhan8.94T
HLB Co., Ltd.6.25T
Peptron6.06T
PharmaResearch5.57T
Market Cap Rankings